How Biotechs can utilise Australia and New Zealand to extend seasonal clinical trials and rescue studies
14 June 2022
Randomised, controlled trials are considered the gold standard in assessing the safety and effectiveness of potential new medicines and therapies.
The Effect of the Pandemic on locations for conducting clinical trials for Biotechs
18 May 2022
Through the spring of 2020, it became evident that the Covid-19 pandemic would have a dual impact on the clinical research sector. While it has provided the opportunity to conduct research for vaccines, treatments, and diagnostic tests for COVID-19; it has also acted as a major disruptive force, halting trials in their tracks, and exacerbating existing fragilities within the sector.
Global Clinical Trials take advantage of significant Australian R&D tax incentives
22 April 2022
Australia and New Zealand are well-established regions for international clinical trials. Global sponsors understand the region’s ability to deliver quality research outcomes; rapid start-up, recruitment and participant retention, streamlined ethics and regulatory pathways, internationally accepted quality data from world-leading research facilities and Investigators.
